Evaluation of endoscope sheaths as viral barriers

被引:19
作者
Baker, EH
Chaput, MP
Clavet, CR
Varney, GW
To, TM
Lytle, CD
机构
[1] US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20852 USA
[2] US FDA, Winchester Engn & Analyt Ctr, Winchester, MA USA
关键词
endoscope sheath; viral barrier; quality assurance;
D O I
10.1097/00005537-199904000-00022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: Evaluate ENT endoscope sheaths as barriers to virus passage. Study Design "Defective" sheaths covering an endoscope were, challenged with virus to determine how many virus particles could be recovered from the endoscope, Methods: Sheaths with small laser-drilled holes (2 to 30 mu m) were challenged with high-titer virus suspensions (10(8) viruses/mL). The inside of the sheath and the endoscope were separately rinsed to recover any virus that penetrated through the hole in the sheath. In an attempt to assess the possible importance of holes in the sheaths, a sequential test was conducted with an initial virus challenge outside a defective sheath (30-micron hole in the sheath), after which the possibly contaminated endoscope was removed and inserted into a second defective sheath (with a 20-micron hole at the same location) to determine whether the contaminating virus would pass outward through the second sheath. Results: Small volumes of virus-containing fluid penetrated through the hole, e.g;, 500 virus particles passed through one of three 30-mu m holes. A significant fraction of those virus particles was occasionally found on the endoscope after removal from the sheath, Similar results were obtained with sheaths that had small tears (34-84 mu m in length, from punctures with fine wires), Although some virus penetration could occur during the initial challenge contaminating the endoscope, no virus was detected passing outward through the second sheath. Conclusions: Use of a sheath combined with intermediate level disinfection should provide a safe instrument for ENT endoscopy.
引用
收藏
页码:636 / 639
页数:4
相关论文
共 15 条
  • [1] ABRAMSON AL, 1993, LARYNGOSCOPE, V103, P503
  • [2] *ASTM, 1995, F167195 ASTM
  • [3] TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    DAAR, ES
    MOUDGIL, T
    MEYER, RD
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 961 - 964
  • [4] QUANTITATIVE-ANALYSIS OF HEPATITIS-B VIRUS-DNA IN SALIVA AND SEMEN OF CHRONICALLY INFECTED HOMOSEXUAL MEN
    JENISON, SA
    LEMON, SM
    BAKER, LN
    NEWBOLD, JE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (02) : 299 - 307
  • [5] LEAKAGE OF VIRUS THROUGH USED VINYL AND LATEX EXAMINATION GLOVES
    KORNIEWICZ, DM
    LAUGHON, BE
    CYR, WH
    LYTLE, CD
    LARSON, E
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (04) : 787 - 788
  • [6] KOTILAINEN HR, 1992, AM SOC TEST MATER, V1133, P38, DOI 10.1520/STP19149S
  • [7] An in vitro evaluation of condoms as barriers to a small virus
    Lytle, CD
    Routson, LB
    Seaborn, GB
    Dixon, LG
    Bushar, HF
    Cyr, WH
    [J]. SEXUALLY TRANSMITTED DISEASES, 1997, 24 (03) : 161 - 164
  • [8] DIFFERENTIAL INACTIVATION OF SURROGATE VIRUSES WITH MEROCYANINE-540
    LYTLE, CD
    BUDACZ, AP
    KEVILLE, E
    MILLER, SA
    PRODOUZ, KN
    [J]. PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1991, 54 (03) : 489 - 493
  • [9] Lytle CD, 1997, J AOAC INT, V80, P319
  • [10] Lytle CD, 1998, J TEST EVAL, V26, P587, DOI 10.1520/JTE12117J